Publication at Faculty of Medicine in Hradec Králové |
2017
Abstract
The present review summarizes the current knowledge of evolocumab, its clinical characteristics and its uses in the treatment of hypercholesterolaemia and atherogenic cardiovascular risk in patients with familial hypercholesterolaemia.